Title Lecturer on Medicine, Part-time Institution Brigham and Women's Hospital Address Brigham and Women's Hospital
75 Francis St
Boston MA 02115
|
|
Biography
| University of Toronto, Toronto Canada | BScPharm | 1988 | Pharmacy |
| London Health Sciences Center, London Canada | | 1989 | Pharmacy Practice Residency |
| University of Toronto, Toronto Canada | PharmD | 1996 | Phamacy |
| Henry Ford Hospital, Detroit MI | | 1997 | Fellowship Critical Care Research |
2020
Masters Critical Care Medicine
Overview
John Devlin is a Professor of Pharmacy at Northeastern University and an Associate Scientist in the Division of Pulmonary and Critical Care Medicine at Brigham and Women's Hospital, Boston, MA. His federally funded research program, focused on the detection, prevention and treatment of delirium and disrupted sleep in the ICU, as well as the epidemiology of medication-associated delirium and polypharmacy during and after critical illness, has generated nearly three million in funding and more than 200 publications. He is a member of the editorial boards of Critical Care Medicine and Pharmacotherapy, a past president of the American Delirium Society, and chaired the SCCM 2018 pain, agitation, delirium, immobility and disrupted sleep international clinical practice guidelines.
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R21AHQR8480441001
(Andrea Sikora)
Jul 1, 2022 - Jun 30, 2024
Use of machine learning models for medication regimen complexity to predict critical care pharmacist resources
Role Description: The goal of this study is to train machine learning models to predict critical care pharmacist staffing resources to reduce adverse drug events and improve other outcomes in critically adults
-
2022P000213
(John Devlin)
May 1, 2022 - Apr 30, 2024
A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients
Role Description: The goal of the study is to evaluate the safety and efficacy of inhaled isoflurane when administered vis the Sedana ACD-S device for sedation in mechanically ventilated medical critically ill adults.
-
2020A018257
(John Devlin)
Aug 23, 2021 - Apr 1, 2022
A phase 2, multicenter, randomized, double-blind, placebo-controlled, ascending starting dose finding, safety, and efficacy study of BXCL501 in agitation associated with delirium in ICU patients.
Role Description: To evaluate the dose, safety and efficacy of a new sub-buccal film tab formulation of dexmedetomidine for the treatment of delirium in critically ill adults.
-
R13185760
(John Devlin and Jan Whitehead Busby)
Apr 1, 2021 - Mar 31, 2025
The Network for Investigation of Delirium: Unifying Scientists (NIDUS) 9th to 13th Annual Delirium Bootcamps: a foundation for future exploration.
Role Description: The goal of this conference award is to to formally train and mentor junior investigators interested in conducting research surrounding delirium.
-
R33HL23452
(Sharon Inouye)
Apr 1, 2021 - Mar 31, 2025
NIDUS II: Advanced-stage development and utilization of the NIDUS research infrastructure to advance interdisciplinary aging research in delirium.
Role Description: The goal of this collaborative network to advance scientific research on the causes, mechanisms, outcomes, diagnosis, prevention, and treatment of delirium in older adults.
-
R21/R33AG05797
(Becky Briesacher)
Dec 1, 2018 - Nov 30, 2023
Clarifying the Relationship between Delirium, Alzheimer’s Disease, and Related Dementias
Role Description: The goal of this nationwide and longitudinal study will provide a novel and robust exploration of the critical role that appropriate NH care plays after acute care hospital discharge in patients with delirium, dementia or both.
-
CIHR3456DRX
(Karen Burns)
Sep 1, 2018 - Mar 31, 2022
Canadian Institute Health Research
Frequency of Screening and SBT Technique Trial - North American Weaning Collaboration (FAST-NAWC)
Role Description: The goal of this multicenter, factorial design, randomized controlled trial with concealed allocation, seeks to comparing the effect of Goal: both screening frequency (once versus at least twice daily [ALTD]) and SBT technique (Pressure Support [PS]?+?Positive End-Expiratory Pressure [PEEP] vs T-piece) on the time to successful extubation in 760 critically ill adults who are invasively ventilated for at least 24?h in 20 North American ICUs.
Featured Content
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.